NCT06447077 Impact of a Predetermined Day 5 ET vs. a Predetermined Day 6 ET on Clinical Pregnancy Rate After ICSI Treatment
| NCT ID | NCT06447077 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Infertility Treatment Center Dortmund |
| Condition | Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,400 participants |
| Start Date | 2024-06-26 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,400 participants in total. It began in 2024-06-26 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this prospective multicenter study is to investigate the influence of a predetermined embryo transfer on day 6 compared to a predetermined embryo transfer on day 5. The study population consists of the control group (predetermined embryo transfer on day 5) and the study group (predetermined embryo transfer on day 6). The primary endpoint is the clinical pregnancy rate (detection of a gestational sac) per embryo transfer and the secondary endpoint is the abortion rate per clinical pregnancy. The data from the multicenter study are obtained at three test centers (Fertility Center Dortmund, Fertility Center Essen and Fertility Center Bad Münder).
Eligibility Criteria
Inclusion criteria: The patients to be included should be ≥18 years old. There is no upper age limit. Only ICSI treatments with a single embryo transfer (SET) should be included. Only the first cycle per patient should be evaluated. Exclusion criteria: none
Contact & Investigator
Stefan Dieterle, MD
PRINCIPAL INVESTIGATOR
University of Witten/Herdecke
Frequently Asked Questions
Who can join the NCT06447077 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06447077 currently recruiting?
Yes, NCT06447077 is actively recruiting participants. Contact the research team at dieterle@kinderwunschzentrum.org for enrollment information.
Where is the NCT06447077 trial being conducted?
This trial is being conducted at Dortmund, Germany.
Who is sponsoring the NCT06447077 clinical trial?
NCT06447077 is sponsored by Infertility Treatment Center Dortmund. The principal investigator is Stefan Dieterle, MD at University of Witten/Herdecke. The trial plans to enroll 2,400 participants.